Prolife Industries Limited (NSE:PROLIFE)

Market Cap	306.24M -50.1%
Revenue (ttm)	545.23M -1.7%
Net Income	42.54M -9.1%
EPS	10.39 -9.1%
Shares Out	4.09M
PE Ratio	7.20
Forward PE	n/a
Dividend	0.30 (0.40%)
Ex-Dividend Date	Sep 16, 2025

Volume	1,000
Open	74.80
Previous Close	n/a
Day's Range	74.80 - 74.80
52-Week Range	56.05 - 150.00
Beta	-0.28
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Prolife Industries

Prolife Industries Limited manufactures and sells naphthalene-based intermediates for dyes, pigments, pharmaceuticals, agrochemicals, and others in India. The company offers dihydro thio para toluidine sulfonic acid, amino phenoxy propane sulfonic acid, amino methyl phenoxy sulfonic acid, 2-chloro methyl -3,4- dimethoxy pyridine, octahydro-4b-methyl-9, di amino bisphenoxy ethane, 5-methoxy 6- amino benz imidazole, basic dyes, and PYBIZS. It also produces violet acid. It exports its products to the United States, Spain, Switzerland, Germany, Fra...

• Industry: Industrial Organic Chemicals
• Founded: 1994
• Employees: 66
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: PROLIFE

Financial Performance

In fiscal year 2026, Prolife Industries's revenue was 545.23 million, a decrease of -1.71% compared to the previous year's 554.70 million. Earnings were 42.54 million, a decrease of -9.07%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 3, 2026

Data Sources Report a data error